BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31875910)

  • 1. Potential Impact of BMI on the Aggressiveness of Presentation and Clinical Outcome of Differentiated Thyroid Cancer.
    Matrone A; Ceccarini G; Beghini M; Ferrari F; Gambale C; D'Aqui M; Piaggi P; Torregrossa L; Molinaro E; Basolo F; Vitti P; Santini F; Elisei R
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31875910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of concomitant obesity and diabetes on the aggressiveness and outcomes of differentiated thyroid cancer patients.
    Elbasan O; Yavuz DG
    Arch Endocrinol Metab; 2021 Nov; 65(4):455-461. PubMed ID: 33909380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Impact of Body Mass Index on the Clinical Outcome of Papillary Thyroid Cancer After High-Dose Radioactive Iodine Therapy.
    Cao J; Zhu X; Sun Y; Li X; Yun C; Zhang W
    Front Endocrinol (Lausanne); 2022; 13():870530. PubMed ID: 35721759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
    Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and High Risk Pathological Features of Papillary Thyroid Carcinoma: A Retrospective Analysis of a University Hospital in Pakistan.
    Zaman SU; Awan MS; Sulaiman MA
    Gulf J Oncolog; 2018 May; 1(27):6-10. PubMed ID: 30145545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.
    Prasad PK; Mahajan P; Hawkins DS; Mostoufi-Moab S; Venkatramani R
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28141. PubMed ID: 32275118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory.
    Lamartina L; Durante C; Lucisano G; Grani G; Bellantone R; Lombardi CP; Pontecorvi A; Arvat E; Felicetti F; Zatelli MC; Rossi R; Puxeddu E; Morelli S; Torlontano M; Crocetti U; Montesano T; Giubbini R; Orlandi F; Aimaretti G; Monzani F; Attard M; Francese C; Antonelli A; Limone P; Rossetto R; Fugazzola L; Meringolo D; Bruno R; Tumino S; Ceresini G; Centanni M; Monti S; Salvatore D; Spiazzi G; Mian C; Persani L; Barbaro D; Nicolucci A; Filetti S
    Thyroid; 2017 Dec; 27(12):1490-1497. PubMed ID: 29020892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractionated dosage of radioiodine for the ablation of low-risk differentiated thyroid cancer has no impact on survival.
    Woliński K; Czepczyński R; Stangierski A; Trojanowski M; Rewaj-Łosyk M; Ziemnicka K; Bączyk M; Dyzmann-Sroka A; Ruchała M
    Endokrynol Pol; 2018; 69(3):230-234. PubMed ID: 29504625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
    Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
    Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.
    Qu N; Zhang L; Lu ZW; Ji QH; Yang SW; Wei WJ; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7797-808. PubMed ID: 26695148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything?
    Forleo R; Fralassi N; Maino F; Capezzone M; Brilli L; Pilli T; Cantara S; Castagna MG
    J Endocrinol Invest; 2021 Jan; 44(1):139-144. PubMed ID: 32388842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil Cationic Protein in Patients with Differentiated Thyroid Cancer Treated with Radioactive Iodine 131.
    Zivancevic-Simonovic S; Mihaljevic O; Kostic I; Ilic N; Mihajlovic D; Vasiljevic D; Mijatovic-Teodorovic L; Miletic-Drakulic S; Colic M
    Ann Clin Lab Sci; 2017 Sep; 47(5):541-545. PubMed ID: 29066479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer.
    Tsirona S; Vlassopoulou V; Tzanela M; Rondogianni P; Ioannidis G; Vassilopoulos C; Botoula E; Trivizas P; Datseris I; Tsagarakis S
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):459-63. PubMed ID: 23895145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.
    Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW
    Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of differentiated thyroid cancer during pregnancy in a community University Hospital in Buenos Aires, Argentina.
    Cabezón CA; Carrizo LC; Costanzo PR
    Arq Bras Endocrinol Metabol; 2013 Jun; 57(4):307-11. PubMed ID: 23828435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.